HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ohta, T. Articles by Matsuda, I. Search for Related Content PubMed PubMed Citation Articles by Ohta, T. Articles by Matsuda, I. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol 36, 696-704, Copyright © 1995 by Lipid Research, Inc.

ARTICLES

Structural and functional differences of subspecies of apoA-I- containing lipoprotein in patients with plasma cholesteryl ester transfer protein deficiency

T Ohta, R Nakamura, K Takata, Y Saito, S Yamashita, S Horiuchi and I Matsuda
Department of Pediatrics, Kumamoto University School of Medicine, Japan.

ApoA-I-containing lipoproteins exist in plasma in two main forms: one contains only apoA-I (LpA-I) while the other contains both apoA-I and apoA-II (LpA-I/A-II). We characterized structural and functional changes of these lipoproteins in six patients with cholesteryl ester transfer protein (CETP) deficiency. In these patients, the amount of LpA-I and LpA-I/A-II had increased significantly. Sixty-five percent of plasma apoA-I was associated with LpA-I/A-II, which indicated that LpA- I/A-II was predominant. The chemical composition of both LpA-I and LpA- I/A-II was characterized by increased ratios of neutral to polar lipid, compared with findings in normal subjects. Particle sizes of these lipoproteins shifted to larger diameter ranges, as compared to the size seen in normal subjects. Incubation of patients' LpA-I and LpA-I/A-II with CETP markedly corrected the chemical and physical abnormalities in these lipoproteins. Cholesterol-reducing capacities of these lipoproteins from macrophage foam cells were significantly lower than in normal controls. Cholesterol esterification rates in LpA-I, LpA-I/A- II, and plasma were significantly lower in patients than in normal controls. We propose that the structure and function of LpA-I and LpA- I/A-II are severely affected in the presence of CETP deficiency.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. Moerland, H. Samyn, T. van Gent, M. Jauhiainen, J. Metso, R. van Haperen, F. Grosveld, A. van Tol, and R. de Crom Atherogenic, enlarged, and dysfunctional HDL in human PLTP/apoA-I double transgenic mice J. Lipid Res., December 1, 2007; 48(12): 2622 - 2631. [Abstract] [Full Text] [PDF]

				L. A. Morehouse, E. D. Sugarman, P.-A. Bourassa, T. M. Sand, F. Zimetti, F. Gao, G. H. Rothblat, and A. J. Milici Inhibition of CETP activity by torcetrapib reduces susceptibility to diet-induced atherosclerosis in New Zealand White rabbits J. Lipid Res., June 1, 2007; 48(6): 1263 - 1272. [Abstract] [Full Text] [PDF]

				P. K. Shah Inhibition of CETP as a novel therapeutic strategy for reducing the risk of atherosclerotic disease Eur. Heart J., January 1, 2007; 28(1): 5 - 12. [Abstract] [Full Text] [PDF]

				R. Asleh, R. Miller-Lotan, M. Aviram, T. Hayek, M. Yulish, J. E. Levy, B. Miller, S. Blum, U. Milman, C. Shapira, et al. Haptoglobin Genotype Is a Regulator of Reverse Cholesterol Transport in Diabetes In Vitro and In Vivo Circ. Res., December 8, 2006; 99(12): 1419 - 1425. [Abstract] [Full Text] [PDF]

				A. H.E.M. Klerkx, K. E. Harchaoui, W. A. van der Steeg, S. M. Boekholdt, E. S.G. Stroes, J. J.P. Kastelein, and J. A. Kuivenhoven Cholesteryl Ester Transfer Protein (CETP) Inhibition Beyond Raising High-Density Lipoprotein Cholesterol Levels: Pathways by Which Modulation of CETP Activity May Alter Atherogenesis Arterioscler. Thromb. Vasc. Biol., April 1, 2006; 26(4): 706 - 715. [Abstract] [Full Text] [PDF]

				B. F. Asztalos, K. V. Horvath, K. Kajinami, C. Nartsupha, C. E. Cox, M. Batista, E. J. Schaefer, A. Inazu, and H. Mabuchi Apolipoprotein composition of HDL in cholesteryl ester transfer protein deficiency J. Lipid Res., March 1, 2004; 45(3): 448 - 455. [Abstract] [Full Text] [PDF]

				H. B. Brewer Jr. High-Density Lipoproteins: A New Potential Therapeutic Target for the Prevention of Cardiovascular Disease Arterioscler. Thromb. Vasc. Biol., March 1, 2004; 24(3): 387 - 391. [Full Text]

				R. W. Clark, T. A. Sutfin, R. B. Ruggeri, A. T. Willauer, E. D. Sugarman, G. Magnus-Aryitey, P. G. Cosgrove, T. M. Sand, R. T. Wester, J. A. Williams, et al. Raising High-Density Lipoprotein in Humans Through Inhibition of Cholesteryl Ester Transfer Protein: An Initial Multidose Study of Torcetrapib Arterioscler. Thromb. Vasc. Biol., March 1, 2004; 24(3): 490 - 497. [Abstract] [Full Text]

				Z. Huang, A. Inazu, M.-a. Kawashiri, A. Nohara, T. Higashikata, and H. Mabuchi Dual effects on HDL metabolism by cholesteryl ester transfer protein inhibition in HepG2 cells Am J Physiol Endocrinol Metab, June 1, 2003; 284(6): E1210 - E1219. [Abstract] [Full Text] [PDF]

				D. Baldassarre, M. Amato, L. Pustina, E. Tremoli, C. R. Sirtori, L. Calabresi, and G. Franceschini Increased Carotid Artery Intima-Media Thickness in Subjects With Primary Hypoalphalipoproteinemia Arterioscler. Thromb. Vasc. Biol., February 1, 2002; 22(2): 317 - 322. [Abstract] [Full Text] [PDF]

				Y. Stein, O. Stein, N. Duverger, G. Halperin, Y. Dabach, G. Hollander, and M. Ben-Naim Clearance of Cationized LDL Cholesterol From a Muscle Depot Is Not Enhanced in Human Apolipoprotein A-IV Transgenic Mice Arterioscler. Thromb. Vasc. Biol., January 1, 2000; 20(1): 179 - 184. [Abstract] [Full Text] [PDF]

				A. P. Serdyuk and R. E. Morton Lipid Transfer Inhibitor Protein Defines the Participation of Lipoproteins in Lipid Transfer Reactions : CETP Has No Preference for Cholesteryl Esters in HDL Versus LDL Arterioscler. Thromb. Vasc. Biol., March 1, 1999; 19(3): 718 - 726. [Abstract] [Full Text] [PDF]

				H. C.F. Oliveira, L. Ma, R. Milne, S. M. Marcovina, A. Inazu, H. Mabuchi, and A. R. Tall Cholesteryl Ester Transfer Protein Activity Enhances Plasma Cholesteryl Ester Formation: Studies in CETP Transgenic Mice and Human Genetic CETP Deficiency Arterioscler. Thromb. Vasc. Biol., June 1, 1997; 17(6): 1045 - 1052. [Abstract] [Full Text]

				K. Takata, K. Saku, T. Ohta, M. Takata, H. Bai, S. Jimi, R. Liu, H. Sato, G. Kajiyama, and K. Arakawa A New Case of ApoA-I Deficiency Showing Codon 8 Nonsense Mutation of the ApoA-I Gene Without Evidence of Coronary Heart Disease Arterioscler. Thromb. Vasc. Biol., November 1, 1995; 15(11): 1866 - 1874. [Abstract] [Full Text]

				T. Ohta, K. Saku, K. Takata, R. Nakamura, Y. Ikeda, and I. Matsuda Different Effects of Subclasses of HDL Containing ApoA-I but Not ApoA-II (LpA-I) on Cholesterol Esterification in Plasma and Net Cholesterol Efflux From Foam Cells Arterioscler. Thromb. Vasc. Biol., July 1, 1995; 15(7): 956 - 962. [Abstract] [Full Text]